Dr.Kumud Sarin - Sr. program director,BII was one of the distinguished invitee at the Inaugral session of seminar.She addressed the audience at inaugral session along with other dignitaries During session she presented the paper and was one of the penalist in the concluding session and concluded seminar by delivering the overview of seminar's outcomes and suggestion as addressed by the other speakers.
Thursday, November 27, 2008
Friday, November 21, 2008
Wednesday, November 19, 2008
Regulatory Affairs :Recession Resistant
Clinical research organizations seems to be far away from global crunch as there is no near term impact of recession as major customers such as astrazeneca and glaxo continue to outsource more work to India.so India is getting more offshore work related to regulatory compliance and regulatory filing at one-fifth the US cost.
The $200-million regulatory affairs related Indian clinical research outsourcing market will escalate to $600 million by 2010,according to joint study done by research firm KPMG & CII.
India is the best destination for conducting global clinical trials because of faster enrollments,faster regulatory filings,speed up regulatory procedures.Eventually more man power is needed,so as to be at par with the increasing demand in this sector.Biopharmaceuticals companies are the key players with many major projects relating to regulatory clinical trials in pipeline.
Major players such as Biocon continue to get tremendous offshore work relating to regulatory clinical projects .”There is possibility that the global meltdown could mean a substantial increase in the revenues thus generated over the next few years.
The $200-million regulatory affairs related Indian clinical research outsourcing market will escalate to $600 million by 2010,according to joint study done by research firm KPMG & CII.
India is the best destination for conducting global clinical trials because of faster enrollments,faster regulatory filings,speed up regulatory procedures.Eventually more man power is needed,so as to be at par with the increasing demand in this sector.Biopharmaceuticals companies are the key players with many major projects relating to regulatory clinical trials in pipeline.
Major players such as Biocon continue to get tremendous offshore work relating to regulatory clinical projects .”There is possibility that the global meltdown could mean a substantial increase in the revenues thus generated over the next few years.
Thursday, November 13, 2008
Letter For Dr.Kumud Sarin : Senior Program Director
Dear Dr. Kumud Sarin Ji,
Sub: -Seminar on “Clinical Trials: The Heart of Medical Science” on 4th November 2008 at ASSOCHAM House, 47 Prithvi Raj Road, Opp. Safdarjung Tomb, New Delhi-110011
We are indeed thankful to you for the valuable time spared by you regarding your participation and excellent presentation in the above conference.
The participants appreciated your presentation which was very nicely presented by you and all of us benefited by the knowledge provided by you.
We thank you once again and look forward to your continued co-operation.
With kind regards,
Yours sincerely,
S. S. Chawla
Director (E & E),
Former Senior AdviserMinistry of Finance,
Govt. of India
Mob: -9810050681,
E-mail: s.s.chawla@assocham.com
Sub: -Seminar on “Clinical Trials: The Heart of Medical Science” on 4th November 2008 at ASSOCHAM House, 47 Prithvi Raj Road, Opp. Safdarjung Tomb, New Delhi-110011
We are indeed thankful to you for the valuable time spared by you regarding your participation and excellent presentation in the above conference.
The participants appreciated your presentation which was very nicely presented by you and all of us benefited by the knowledge provided by you.
We thank you once again and look forward to your continued co-operation.
With kind regards,
Yours sincerely,
S. S. Chawla
Director (E & E),
Former Senior AdviserMinistry of Finance,
Govt. of India
Mob: -9810050681,
E-mail: s.s.chawla@assocham.com
Wednesday, November 12, 2008
Must Visit: CPhl India 2008
With India's pharmaceutical market growing at exponential rate, dodn't miss your chance to be one of the many visitors over 80 countries who benefit from this unique networking and buisness opportunity.
Visit : http://www.icsexpo.com,www.p-mec.com/
Dates and opening hours
Friday 28 November 10.00 - 18.00
Saturday 29 November 10.00 – 18.00
Sunday 30 November 10.00 - 1800
Please note that P-MEC will be open from 27-30 November
Venue Address
Bombay Exhibition Centre
Halls 5 and 6,
Western Express highway,
Goregaon
(East) Mumbai 400063,
India
Visit : http://www.icsexpo.com,www.p-mec.com/
Dates and opening hours
Friday 28 November 10.00 - 18.00
Saturday 29 November 10.00 – 18.00
Sunday 30 November 10.00 - 1800
Please note that P-MEC will be open from 27-30 November
Venue Address
Bombay Exhibition Centre
Halls 5 and 6,
Western Express highway,
Goregaon
(East) Mumbai 400063,
India
Thursday, November 6, 2008
Letter for Dr Kumud Sarin : Senior Program Director
Dear Dr. Kumud Sarin Ji,
Sub: -Seminar on “Clinical Trials: The Heart of Medical Science” on 4th November 2008 at ASSOCHAM House, 47 Prithvi Raj Road, Opp. Safdarjung Tomb, New Delhi-110011
We are indeed thankful to you for the valuable time spared by you regarding your participation and excellent presentation in the above conference.
The participants appreciated your presentation which was very nicely presented by you and all of us benefited by the knowledge provided by you.
We thank you once again and look forward to your continued co-operation.
With kind regards,
Yours sincerely,
S. S. Chawla
Director (E & E),
Former Senior Adviser
Ministry of Finance, Govt. of India
Mob: -9810050681,
E-mail: s.s.chawla@assocham.com
Sub: -Seminar on “Clinical Trials: The Heart of Medical Science” on 4th November 2008 at ASSOCHAM House, 47 Prithvi Raj Road, Opp. Safdarjung Tomb, New Delhi-110011
We are indeed thankful to you for the valuable time spared by you regarding your participation and excellent presentation in the above conference.
The participants appreciated your presentation which was very nicely presented by you and all of us benefited by the knowledge provided by you.
We thank you once again and look forward to your continued co-operation.
With kind regards,
Yours sincerely,
S. S. Chawla
Director (E & E),
Former Senior Adviser
Ministry of Finance, Govt. of India
Mob: -9810050681,
E-mail: s.s.chawla@assocham.com
Wednesday, November 5, 2008
Subscribe to:
Posts (Atom)